Biomarkers are crucial for translating therapies, validating hypotheses, and monitoring effects in clinical trials. Identifying biomarkers is time-consuming but essential in preclinical drug discovery. They should be related to the disease or target mechanism and measurable in accessible samples like body fluids.
CETSA can be used to identify and monitor novel biomarkers, guiding optimal treatment strategies for specific patient populations to improve survival rates.
Get in touch
Contact us to learn more, to book a meeting or request a quote.